The content on this site is intended for healthcare professionals only
ASCO GU 2022: What to watch out for in renal
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
21 Feb 2022
Maintenance PARP inhibition following chemotherapy for metastatic urothelial car...
Dr Simon Crabb - University of Southampton, Southampton, UK
21 Feb 2022
First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients...
Prof Alfredo Berruti - University Of Brescia, Brescia, Italy
21 Feb 2022
Durvalumab with olapirib shows no PFS improvement for platinum-ineligible bladde...
Prof Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
21 Feb 2022
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
17 Feb 2022
OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology
Dr Toni Choueiri, Dr Andrea Apolo, Dr Neeraj Agarwal, Dr Piet Ost, Dr Sean McBri...
19 Jan 2022
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
8 Dec 2021
Quality of life and patient perspectives in renal cell carcinoma
Prof Steven Hildemann, Dr Rachel Giles and Prof Gunhild von Amsberg
6 Dec 2021
Comparison of health access, lifestyle, prostate cancer knowledge, and screening...
Dr Orlando Rivera Colón - University of Central Florida, Florida, USA
25 Oct 2021
Advances in prostate cancer in the last 10 years and a glimpse to the future
Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono
21 Oct 2021
OncoAlert and ecancer weekly round up for October 11th - October 16, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
18 Oct 2021
Cancer Health Disparities Special Issue - Editorial
Prof Folakemi Odedina - University of Florida, Tampa, USA
14 Oct 2021